Serum sclerostin and bone turnover in latent autoimmune diabetes in adults.
Conclusions: LADA patients present lower bone resorption compared to controls, similarly to T2D. Sclerostin is increased in T2D but not in LADA suggesting possible roles on bone metabolism in T2D only.
PMID: 29506222 [PubMed - as supplied by publisher]
Source: The Journal of Clinical Endocrinology and Metabolism - Category: Endocrinology Authors: Napoli N, Strollo R, Defeudis G, Leto G, Moretti C, Zampetti S, D'Onofrio L, Campagna G, Palermo A, Greto V, Manfrini S, Hawa MI, Leslie RD, Pozzilli P, Buzzetti R, NIRAD (NIRAD 10) and the ACTION LADA study groups Tags: J Clin Endocrinol Metab Source Type: research
More News: Diabetes | Diabetes Type 1 | Diabetes Type 2 | Endocrinology | Metabolic Syndrome | Study